| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Scharen-Guivel Hilda Frederique is a Director at IRMD. Recent filings cover 0 purchases and 2 sales. Those positions are worth an estimated $532K at current prices.
Scharen-Guivel Hilda Frederique's largest disclosed position is in IRMD as Director, worth about $532K. The recent filings there lean toward selling, a net 3,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | IRMD Iradimed Corporation | Director | Sell | 3,000 | $95.00 | $285,000.00 | -34.9% | -7.9% | - |